Table 1.
Pooled (N=3531) |
MDRD (N=840) |
AASK (N=1094) |
CSG (N=360) |
DCCT (N=1237) |
|
---|---|---|---|---|---|
Age, years | 43 ± 15 | 52 ± 12 | 55 ± 11 | 34 ± 8 | 30 ± 7 |
Female | 1491 (42%) | 332 (40%) | 424 (39%) | 169 (47%) | 566 (46%) |
Black | 1226 (35%) | 66 (8%) | 1094 (100%) | 24 (7%) | 42 (3%) |
Diabetes | 1640 (46%) | 43 (5%) | 0 (0%) | 360 (100%) | 1237 (100%) |
BMI, kg/m2 | 27 ± 5 | 27 ± 5 | 31 ± 7 | 25 ± 4 | 25 ± 3 |
BSA m2 | 1.9 ± 0.2 | 1.9 ± 0.2 | 2.0 ± 0.2 | 1.8 ± 0.2 | 1.9 ± 0.2 |
Serum creatinine, mg/dL | 1.5 ± 0.8 | 2.2 ± 0.9 | 1.8 ± 0.6 | 1.2 ± 0.5 | 0.8 ± 0.1 |
mGFR, mL/min/1.73 m2 | 73 ± 43 | 33 ± 12 | 46 ± 13 | 75 ± 33 | 124 ± 22 |
eGFR, mL/min/1.73 m2 | 73 ± 38 | 36 ± 14 | 50 ± 16 | 77 ± 28 | 117 ± 13 |
Values are mean ± SD or n (%). eGFR calculated using the CKD-EPI equation.
Conversion factors for units: serum creatinine in mg/dL to micromol/L, ×88.4; GFR in ml/min/1.73 m2 to ml/s/1.73 m2, ×0.01667.
MDRD - Modification of Diet in Renal Disease; AASK - African American Study of Kidney Disease and Hypertension; CSG - Collaborative Study Group; DCCT - Diabetes Control and Complications Trial; eGFR, estimated glomerular filtration rate; mGFR, measured glomerular filtration rate; BSA, body surface area; BMI, body mass index.